NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 89 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,711,000 | +220.6% | 15,575,946 | +351.5% | 89.51% | +31.9% |
| Q4 2015 | $4,588,000 | -84.2% | 3,449,969 | -72.8% | 67.86% | -27.1% |
| Q3 2015 | $28,970,000 | +47.6% | 12,706,324 | +4.2% | 93.08% | +8.0% |
| Q2 2015 | $19,630,000 | +7.8% | 12,192,327 | +6.4% | 86.22% | -8.5% |
| Q1 2015 | $18,213,000 | -34.0% | 11,454,831 | -21.6% | 94.21% | +59.2% |
| Q4 2014 | $27,601,000 | +39.0% | 14,603,603 | -2.9% | 59.19% | +1200.0% |
| Q3 2014 | $19,861,000 | -10.0% | 15,046,431 | +0.9% | 4.55% | +45.4% |
| Q2 2014 | $22,075,000 | -15.2% | 14,915,631 | +6.0% | 3.13% | -74.5% |
| Q1 2014 | $26,036,000 | +92.2% | 14,073,431 | +35.6% | 12.30% | -37.8% |
| Q4 2013 | $13,549,000 | -45.4% | 10,375,329 | +10.8% | 19.76% | +48.2% |
| Q3 2013 | $24,807,000 | +1.1% | 9,361,276 | +1.8% | 13.33% | +54.4% |
| Q2 2013 | $24,549,000 | – | 9,194,517 | – | 8.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sowell Financial Services LLC | 1,507,457 | $593,000 | 0.17% |
| Harel Insurance Investments & Financial Services Ltd. | 780,000 | $398,000 | 0.03% |
| Spark Investment Management LLC | 353,400 | $180,000 | 0.01% |
| LifePlan Financial Group, Inc | 28,810 | $15,000 | 0.01% |
| Greenwich Wealth Management LLC | 60,066 | $31,000 | 0.01% |
| SHINE INVESTMENT ADVISORY SERVICES INC | 19,608 | $10,000 | 0.01% |
| Virtu KCG Holdings LLC | 336,414 | $172,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $9,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $331,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377,875 | $193,000 | 0.00% |